What the studies show
The intravenous route is the one most heavily marketed and the least studied. Regulators in several countries have warned against it, and injecting an unapproved product carries risks the skin trials never measured.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
- 1
In context
Glutathione is a three-amino-acid molecule every cell makes and uses to handle oxidative stress. It is sold orally and, in some countries, intravenously for skin lightening. Systematic reviews of the small trials find it may brighten sun-exposed skin slightly, but call the evidence inconclusive because the studies are few, small and inconsistent. Oral absorption is itself questionable, and the intravenous use that carries the most risk has the least evidence — in 2026 the FDA linked at least 30 adverse events, some needing hospital care, to injectables compounded from supplement-grade glutathione contaminated with endotoxin.
Glutathione is supplement; injectable use unapproved. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Glutathione proven to help with intravenous use for skin?
What studies are behind the grade?
Is Glutathione approved for this?
Other outcomes for Glutathione
- CSkin lightening4 studies in systematic review (3 RCTs)
- COral bioavailabilityadverseReviews
- BEndotoxin reactions from compounded injectablesadverseFDA case series (≥30 patients); recalls
- CSafety (oral, short-term)adverseSmall trials
Written and maintained by LYO Research — how pages are written and checked. Reviewed 7 October 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →